Top Banner
Palliation With Palliation With Endoluminal Stents Endoluminal Stents Todd H. Baron, M.D., Todd H. Baron, M.D., F.A.C.P. F.A.C.P. Professor of Medicine Professor of Medicine Gastroenterology & Gastroenterology & Hepatology Hepatology Mayo Clinic College of Mayo Clinic College of Medicine Medicine
28

Palliation With Endoluminal Stents Todd H. Baron, M.D., F.A.C.P. Professor of Medicine Gastroenterology & Hepatology Mayo Clinic College of Medicine.

Dec 17, 2015

Download

Documents

Shona McDowell
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Palliation With Endoluminal Stents Todd H. Baron, M.D., F.A.C.P. Professor of Medicine Gastroenterology & Hepatology Mayo Clinic College of Medicine.

Palliation With Endoluminal Palliation With Endoluminal StentsStents

Todd H. Baron, M.D., F.A.C.P.Todd H. Baron, M.D., F.A.C.P.

Professor of MedicineProfessor of Medicine

Gastroenterology & HepatologyGastroenterology & Hepatology

Mayo Clinic College of MedicineMayo Clinic College of Medicine

Page 2: Palliation With Endoluminal Stents Todd H. Baron, M.D., F.A.C.P. Professor of Medicine Gastroenterology & Hepatology Mayo Clinic College of Medicine.
Page 3: Palliation With Endoluminal Stents Todd H. Baron, M.D., F.A.C.P. Professor of Medicine Gastroenterology & Hepatology Mayo Clinic College of Medicine.

Enteral StentsEnteral Stents

Page 4: Palliation With Endoluminal Stents Todd H. Baron, M.D., F.A.C.P. Professor of Medicine Gastroenterology & Hepatology Mayo Clinic College of Medicine.

Malignant Gastric Outlet Malignant Gastric Outlet ObstructionObstruction

Page 5: Palliation With Endoluminal Stents Todd H. Baron, M.D., F.A.C.P. Professor of Medicine Gastroenterology & Hepatology Mayo Clinic College of Medicine.

Clinical SituationsClinical Situations• Unresectable CAUnresectable CA

pancreatic, GB, Cholangiopancreatic, GB, Cholangio• Metastatic diseaseMetastatic disease• Local invasion - colonLocal invasion - colon• Gastric CAGastric CA• primaryprimary•RecurrentRecurrent

Page 6: Palliation With Endoluminal Stents Todd H. Baron, M.D., F.A.C.P. Professor of Medicine Gastroenterology & Hepatology Mayo Clinic College of Medicine.

SEMS: OverviewSEMS: Overview

• May be placed endoscopically or May be placed endoscopically or radiologicallyradiologically

• Non-TTS difficult but possibleNon-TTS difficult but possible

• TTS placement - can be placed TTS placement - can be placed beyond ligament of Treitz - beyond ligament of Treitz - uncovereduncovered

Page 7: Palliation With Endoluminal Stents Todd H. Baron, M.D., F.A.C.P. Professor of Medicine Gastroenterology & Hepatology Mayo Clinic College of Medicine.

WallstentWallstent

• Delivery diameter: Delivery diameter: 10F10F

• Deployed diameter: Deployed diameter:

20mm20mm

22mm22mm

• TTSTTS

Page 8: Palliation With Endoluminal Stents Todd H. Baron, M.D., F.A.C.P. Professor of Medicine Gastroenterology & Hepatology Mayo Clinic College of Medicine.
Page 9: Palliation With Endoluminal Stents Todd H. Baron, M.D., F.A.C.P. Professor of Medicine Gastroenterology & Hepatology Mayo Clinic College of Medicine.
Page 10: Palliation With Endoluminal Stents Todd H. Baron, M.D., F.A.C.P. Professor of Medicine Gastroenterology & Hepatology Mayo Clinic College of Medicine.
Page 11: Palliation With Endoluminal Stents Todd H. Baron, M.D., F.A.C.P. Professor of Medicine Gastroenterology & Hepatology Mayo Clinic College of Medicine.
Page 12: Palliation With Endoluminal Stents Todd H. Baron, M.D., F.A.C.P. Professor of Medicine Gastroenterology & Hepatology Mayo Clinic College of Medicine.
Page 13: Palliation With Endoluminal Stents Todd H. Baron, M.D., F.A.C.P. Professor of Medicine Gastroenterology & Hepatology Mayo Clinic College of Medicine.
Page 14: Palliation With Endoluminal Stents Todd H. Baron, M.D., F.A.C.P. Professor of Medicine Gastroenterology & Hepatology Mayo Clinic College of Medicine.
Page 15: Palliation With Endoluminal Stents Todd H. Baron, M.D., F.A.C.P. Professor of Medicine Gastroenterology & Hepatology Mayo Clinic College of Medicine.

ENDO ENDO GASTRO-JGASTRO-J p p

Number of patients Number of patients 1212 15 15

Median survival (days) Median survival (days) 9494 9292 NS NS

Median charges incurred Median charges incurred $9921 $9921 $28,173 $28,173 < 0.005 < 0.005

Median hospitalizationMedian hospitalization stay required (days) stay required (days) 4 4 14 14 < 0.005< 0.005

Number requiring repeat procedures Number requiring repeat procedures and hospitalization and hospitalization 7 (58.3%) 7 (58.3%) 15 (100%) 15 (100%)

Yim, et al., GIE, 2001Yim, et al., GIE, 2001

Cost of Palliation: Pancreatic CACost of Palliation: Pancreatic CA

Page 16: Palliation With Endoluminal Stents Todd H. Baron, M.D., F.A.C.P. Professor of Medicine Gastroenterology & Hepatology Mayo Clinic College of Medicine.
Page 17: Palliation With Endoluminal Stents Todd H. Baron, M.D., F.A.C.P. Professor of Medicine Gastroenterology & Hepatology Mayo Clinic College of Medicine.
Page 18: Palliation With Endoluminal Stents Todd H. Baron, M.D., F.A.C.P. Professor of Medicine Gastroenterology & Hepatology Mayo Clinic College of Medicine.
Page 19: Palliation With Endoluminal Stents Todd H. Baron, M.D., F.A.C.P. Professor of Medicine Gastroenterology & Hepatology Mayo Clinic College of Medicine.

Malignant Colorectal Malignant Colorectal ObstructionObstruction

Page 20: Palliation With Endoluminal Stents Todd H. Baron, M.D., F.A.C.P. Professor of Medicine Gastroenterology & Hepatology Mayo Clinic College of Medicine.

Metal Colonic StentsMetal Colonic Stents• Wilson-Cook Z stentWilson-Cook Z stent

• Microvasive WallstentMicrovasive Wallstent

• Precision Ultraflex ColonicPrecision Ultraflex Colonic

OTHEROTHER• Ultraflex Esophageal StentUltraflex Esophageal Stent

Page 21: Palliation With Endoluminal Stents Todd H. Baron, M.D., F.A.C.P. Professor of Medicine Gastroenterology & Hepatology Mayo Clinic College of Medicine.

Colonic Z-StentColonic Z-Stent

• Delivery diameter:Delivery diameter:

10mm (30F)10mm (30F)

• Deployed diameter: Deployed diameter: 35/25mm35/25mm

Page 22: Palliation With Endoluminal Stents Todd H. Baron, M.D., F.A.C.P. Professor of Medicine Gastroenterology & Hepatology Mayo Clinic College of Medicine.

Indications for Colorectal StentsIndications for Colorectal Stents

• Pre-operativePre-operative

• PalliativePalliative

• IndeterminateIndeterminate

Page 23: Palliation With Endoluminal Stents Todd H. Baron, M.D., F.A.C.P. Professor of Medicine Gastroenterology & Hepatology Mayo Clinic College of Medicine.
Page 24: Palliation With Endoluminal Stents Todd H. Baron, M.D., F.A.C.P. Professor of Medicine Gastroenterology & Hepatology Mayo Clinic College of Medicine.

Potential Benefits ofPotential Benefits ofPre-operative Colon StentsPre-operative Colon Stents

• One-stage operationOne-stage operation

• Reduced costsReduced costs

• Improved QOLImproved QOL

• Elective operationElective operation

• Pre-operative assessmentPre-operative assessment

tumor resectabilitytumor resectability

patient operabilitypatient operability

Page 25: Palliation With Endoluminal Stents Todd H. Baron, M.D., F.A.C.P. Professor of Medicine Gastroenterology & Hepatology Mayo Clinic College of Medicine.
Page 26: Palliation With Endoluminal Stents Todd H. Baron, M.D., F.A.C.P. Professor of Medicine Gastroenterology & Hepatology Mayo Clinic College of Medicine.

Complications of Enteral Stents Complications of Enteral Stents • Tumor ingrowth/overgrowthTumor ingrowth/overgrowth

• MigrationMigration

• PerforationPerforation

immediateimmediate

delayeddelayed

• Impaction Impaction

• BleedingBleeding

• Pain/TenesmusPain/Tenesmus

Page 27: Palliation With Endoluminal Stents Todd H. Baron, M.D., F.A.C.P. Professor of Medicine Gastroenterology & Hepatology Mayo Clinic College of Medicine.
Page 28: Palliation With Endoluminal Stents Todd H. Baron, M.D., F.A.C.P. Professor of Medicine Gastroenterology & Hepatology Mayo Clinic College of Medicine.

ConclusionsConclusions• SEMS are effective for closing TEF and SEMS are effective for closing TEF and

treating all forms of malignant treating all forms of malignant esophageal obstructionesophageal obstruction

• SEMS are cost-effective for palliation of SEMS are cost-effective for palliation of malignant GOO for pancreatic CAmalignant GOO for pancreatic CA

• SEMS can be used for both pre-SEMS can be used for both pre-operative and palliative treatment of operative and palliative treatment of malignant colonic obstruction malignant colonic obstruction